HUP0401588A3 - Indeno[1,2-c]pyrazol-4-one derivatives useful as anti-cancer and anti-proliferative agents and pharmaceutical compositions containing them - Google Patents
Indeno[1,2-c]pyrazol-4-one derivatives useful as anti-cancer and anti-proliferative agents and pharmaceutical compositions containing themInfo
- Publication number
- HUP0401588A3 HUP0401588A3 HU0401588A HUP0401588A HUP0401588A3 HU P0401588 A3 HUP0401588 A3 HU P0401588A3 HU 0401588 A HU0401588 A HU 0401588A HU P0401588 A HUP0401588 A HU P0401588A HU P0401588 A3 HUP0401588 A3 HU P0401588A3
- Authority
- HU
- Hungary
- Prior art keywords
- indeno
- pyrazol
- cancer
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- GHFDYLOGYDGRHI-UHFFFAOYSA-N 1h-indeno[1,2-c]pyrazol-4-one Chemical class C12=CC=CC=C2C(=O)C2=C1NN=C2 GHFDYLOGYDGRHI-UHFFFAOYSA-N 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/906,963 US6593356B2 (en) | 1999-10-20 | 2001-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| PCT/US2002/022663 WO2003007883A2 (en) | 2001-07-16 | 2002-07-16 | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401588A2 HUP0401588A2 (hu) | 2005-01-28 |
| HUP0401588A3 true HUP0401588A3 (en) | 2005-06-28 |
Family
ID=25423309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401588A HUP0401588A3 (en) | 2001-07-16 | 2002-07-16 | Indeno[1,2-c]pyrazol-4-one derivatives useful as anti-cancer and anti-proliferative agents and pharmaceutical compositions containing them |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6593356B2 (https=) |
| EP (1) | EP1417177A4 (https=) |
| JP (1) | JP2004536853A (https=) |
| KR (1) | KR20040015368A (https=) |
| CN (1) | CN1553900A (https=) |
| BR (1) | BR0211203A (https=) |
| CA (1) | CA2453594A1 (https=) |
| HU (1) | HUP0401588A3 (https=) |
| IL (1) | IL159863A0 (https=) |
| MX (1) | MXPA04000531A (https=) |
| NO (1) | NO20040175L (https=) |
| PL (1) | PL366912A1 (https=) |
| RU (1) | RU2004104329A (https=) |
| WO (1) | WO2003007883A2 (https=) |
| ZA (1) | ZA200400332B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040048844A1 (en) * | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| JP3821090B2 (ja) * | 2002-10-22 | 2006-09-13 | トヨタ自動車株式会社 | 内燃機関の始動制御装置 |
| US7456169B2 (en) | 2003-02-27 | 2008-11-25 | Abbott Laboratories Inc. | Heterocyclic kinase inhibitors |
| US7320986B2 (en) | 2003-03-07 | 2008-01-22 | Abbott Labortories | Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| EP1740579B1 (en) | 2004-03-24 | 2015-08-19 | AbbVie Inc. | Tricyclic pyrazole kinase inhibitors |
| US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
| US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
| US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
| JP5795584B2 (ja) | 2009-08-31 | 2015-10-14 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 医療用装置 |
| ES2881798T3 (es) | 2010-03-24 | 2021-11-30 | Abbott Diabetes Care Inc | Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos |
| AU2012352560B2 (en) | 2011-12-11 | 2017-01-19 | Abbott Diabetes Care Inc. | Analyte sensor devices, connections, and methods |
| US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
| MX2018006250A (es) | 2015-11-18 | 2018-09-05 | Genzyme Corp | Biomarcador de enfermedad poliquistica renal y usos del mismo. |
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
| CN114641466B (zh) | 2019-06-12 | 2025-09-30 | 诺瑟拉有限公司 | 磺酰脲衍生物及其用途 |
| USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407103B2 (en) * | 1998-04-21 | 2002-06-18 | Bristol-Myers Squibb Pharma Company | Indeno [1,2-c] pyrazol-4-ones and their uses |
| JP4665239B2 (ja) | 1998-04-21 | 2011-04-06 | アゲンニクス アーゲー | 抗癌剤および抗増殖性薬剤としての５−アミノインデノ［１，２−ｃ］ピラゾール−４−オン |
| US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
| AU2001212168A1 (en) * | 2000-10-20 | 2002-05-06 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides and their use as cyclin dependent kinase (CDK) inhibitors |
| WO2002044174A2 (en) * | 2000-12-01 | 2002-06-06 | Bristol-Myers Squibb Pharma Company | 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors |
-
2001
- 2001-07-16 US US09/906,963 patent/US6593356B2/en not_active Expired - Lifetime
-
2002
- 2002-07-16 EP EP02748186A patent/EP1417177A4/en not_active Withdrawn
- 2002-07-16 CA CA002453594A patent/CA2453594A1/en not_active Abandoned
- 2002-07-16 HU HU0401588A patent/HUP0401588A3/hu unknown
- 2002-07-16 CN CNA028177614A patent/CN1553900A/zh active Pending
- 2002-07-16 MX MXPA04000531A patent/MXPA04000531A/es unknown
- 2002-07-16 IL IL15986302A patent/IL159863A0/xx unknown
- 2002-07-16 JP JP2003513492A patent/JP2004536853A/ja not_active Abandoned
- 2002-07-16 BR BR0211203-5A patent/BR0211203A/pt not_active IP Right Cessation
- 2002-07-16 PL PL02366912A patent/PL366912A1/xx not_active Application Discontinuation
- 2002-07-16 RU RU2004104329/04A patent/RU2004104329A/ru not_active Application Discontinuation
- 2002-07-16 KR KR10-2004-7000762A patent/KR20040015368A/ko not_active Withdrawn
- 2002-07-16 WO PCT/US2002/022663 patent/WO2003007883A2/en not_active Ceased
-
2004
- 2004-01-15 NO NO20040175A patent/NO20040175L/no unknown
- 2004-01-15 ZA ZA2004/00332A patent/ZA200400332B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6593356B2 (en) | 2003-07-15 |
| EP1417177A4 (en) | 2005-10-19 |
| NO20040175L (no) | 2004-03-12 |
| WO2003007883A3 (en) | 2003-05-22 |
| ZA200400332B (en) | 2005-06-29 |
| US20030073686A1 (en) | 2003-04-17 |
| RU2004104329A (ru) | 2005-07-10 |
| EP1417177A2 (en) | 2004-05-12 |
| CA2453594A1 (en) | 2003-01-30 |
| WO2003007883A2 (en) | 2003-01-30 |
| BR0211203A (pt) | 2004-09-28 |
| HUP0401588A2 (hu) | 2005-01-28 |
| KR20040015368A (ko) | 2004-02-18 |
| CN1553900A (zh) | 2004-12-08 |
| JP2004536853A (ja) | 2004-12-09 |
| IL159863A0 (en) | 2004-06-20 |
| MXPA04000531A (es) | 2004-05-04 |
| PL366912A1 (en) | 2005-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
| HUP0400114A3 (en) | N-benzoyl-benzenesulfonamid derivatives as antitumor agents and pharmaceutical compositions containing them | |
| HUP0401588A3 (en) | Indeno[1,2-c]pyrazol-4-one derivatives useful as anti-cancer and anti-proliferative agents and pharmaceutical compositions containing them | |
| IL150539A0 (en) | Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them | |
| HUP0402026A3 (en) | 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303825A3 (en) | 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them | |
| IL176005A0 (en) | 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL158523A0 (en) | Epothilone derivatives and pharmaceutical compositions containing the same | |
| IL161616A0 (en) | Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same | |
| HUP0401567A3 (en) | Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them | |
| IL154306A0 (en) | Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof | |
| IL158044A0 (en) | Cyclopropylindole derivatives and pharmaceutical compositions containing the same | |
| IL158300A0 (en) | Bisarylimidazol derivatives and pharmaceutical compositions containing the same | |
| IL161623A (en) | Nicotin-or isonicotin benzothiazole derivatives, their preparation and pharmaceutical compositions comprising them | |
| IL151209A0 (en) | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation | |
| IL144501A0 (en) | Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0400246A3 (en) | 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use | |
| IL147923A0 (en) | 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents | |
| EP1202734A4 (en) | 3 (5) -UREIDO-PYRAZOLE DERIVATIVES, THEIR METHODS OF PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | |
| IL192937A0 (en) | Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same | |
| HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
| IL156812A0 (en) | Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same | |
| HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
| IL156988A0 (en) | Pharmaceutical compositions containing epothilone derivatives | |
| IL157128A0 (en) | Pharmaceutical compositions containing epothilone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |